Emerging market stocks saw record inflows in the week to Wednesday, Barclays said citing data from EPFR, led by record ...

Analysts upgraded shares of the healthcare company to Overweight from Equal Weight and raised their price target to $82.

A recently released negative study by Novo Nordisk (NVO) on the differences between its own semaglutide and liraglutide ...

Barclays claim the incentive could encourage older people to give up family homes that are too large for them.

Barclays initiated coverage of Shift4 Payments (FOUR) with an Overweight rating and a price target of $120, considering the ...

Barclays analyst Raimo Lenschow maintained a Buy rating on ServiceNow (NOW – Research Report) today and set a price target of $980.00.

CHICAGO (WLS) -- A group of pro-Palestinian protesters blocked off an entrance to a building in the Loop Thursday. They are ...

European companies are heading into the upcoming earnings season on shaky ground, but lowered earnings estimates could help ...

Barclays analyst Lauren Lieberman maintained a Hold rating on The Estée Lauder Companies (EL – Research Report) today and set a price ...

CVS Health (CVS) stock gained as Barclays upgraded the company, citing a compelling path to margin recovery in its Medicare ...

Cineworld Group Plc is working with Barclays Plc and Deutsche Bank AG to talk to investors about refinancing debt to lower ...

Robinhood Markets shares jumped Tuesday as the online trading platform announced it would hold its first investor day on Dec.